Company Overview
Snapshot
Founded in October 2009 by Adva Beck, NozNoz operates with 1–10 employees. The company has developed a nasal device designed to aid in weight management by reducing the sense of smell, a product that has been tested in pilot clinical trials.
Business overview
NozNoz, developed by Beck Medical, is a Health Tech & Life Sciences company focused on weight management. Its core product is a mechanical nasal device designed to be inserted into the nostrils to reduce the sense of smell, thereby curbing appetite and promoting weight loss. The device is drug-free and targets consumers in the weight loss and wellness markets, operating within the Biomaterials & Tissue Engineering and Materials & Substances sectors.
Strategic signal
In July 2019, NozNoz's wellness wearable, designed to reduce the sense of smell for weight management, became available for purchase. This development signals the company's transition from clinical testing to market availability, indicating a focus on commercialization and direct-to-consumer sales within the wellness and weight loss industry.
Log in to access full profile ›Company Intelligence Q&A
- What is the primary function of the NozNoz device?
- The NozNoz device is designed to be inserted into the nostrils to mechanically reduce the sense of smell, which helps to curb appetite and promote weight loss without using active ingredients or drugs.
- When was NozNoz made available for purchase?
- In July 2019, the NozNoz device became available for purchase, offering a drug-free solution for weight management.
- What were the findings of the pilot clinical trial for NozNoz?
- In October 2018, a small pilot clinical trial for NozNoz showed that users experienced significant weight loss compared to a control group, particularly for participants aged 50 and younger.
- Which markets does NozNoz currently serve?
- As of September 2018, NozNoz was available online to customers in the European Union, the United States, and Israel.
- What are NozNoz's future product development plans?
- In October 2018, NozNoz announced plans to develop additional models of its nasal device and explore other nasal-based technologies to address conditions such as smoking, diabetes, and drug use.